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Abstract
The cytotoxicity of ciprofloxacin was investigated in culture of Giardia lamblia (ATCC 30957), used as an in vitro cellular model,
on the basis of cell growth, morphology, viability, adherence and metabolic studies. The effects on cell membrane integrity were
evaluated by permeability of the cells to trypan blue, and the morphological alterations were studied by optical and transmission
electronic microscopy. The metabolic studies were performed by measured oxygen uptake with a Clark-type oxygen electrode. Our
data show that ciprofloxacin induces loss of viability with morphological alterations and loss of membrane integrity. Ultra-
structural observations revealed that this drug promoted modifications on the cell shape, pronounced dorsal vesiculation, plasma
membrane blebbing, disaggregation of ribosome, coagulation of cytoplasmic matrix, and heavy deposit of electron-dense pre-
cipitates on the cytoplasm and nucleus. Ciprofloxacin also inhibits parasite growth, adherence and O2 uptake in a concentration-
dependent manner. Some of these observations suggest that cytotoxicity of ciprofloxacin results in cell death by a necrosis process.
We demonstrate that ciprofloxacin has a lethal effect in G. lamblia trophozoites and could be used as an alternative drug in giar-
diasis treatment, particularly in infections that are resistant to other antibiotics. # 2001 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Giardia lamblia is a binucleated flagellated protozoan
that causes infection of the small intestine that may give
rise to diarrhoea with or without malabsorption. This
parasite is endemic throughout the world and it is one
of the most frequently found intestinal parasites in chil-
dren living in developing countries. Although various
drugs have been available for several decades to treat
this infection, none is entirely satisfactory due to the high
incidence of undesirable side-effects and a significant
failure rate in clearing parasites from the gastrointestinal
tract. Some evidence suggests that drug resistance may
be responsible for these failures (Kulda and Nohyhova´,
1995; Barat and Bloland, 1997). Therefore, there is an
obvious need for alternative antigiardial agents.
The fluoroquinolone antibiotics such as ciprofloxacin
have excellent activity in vitro against bacterial patho-
gens of the gastrointestinal tract including Escherichia
coli, Salmonella spp., Shigella spp., Yersinia enter-
ocolı´tica, Campylobacter jejuni and Vibrio spp. Bacterial
DNA gyrase has been identified as the primary target
for quinolone (Kidwai et al., 1998). However, the
understanding of the molecular mechanisms leading to
loss of bacterial viability remains incomplete. Some
investigators have suggested that quinolones induce
membrane permeability changes and that these lead to
loss of integrity, leakage of cytoplasmic constituents,
and cell death (Dougherty and Saukkonen, 1985; Elliot
et al., 1987).
Ikerd and Koletar (1993), using a macrodilution
method in a semi-solid media, reported antigiardial
activity of fluoroquinolones and macrolides.
These findings prompt us to study in vitro effects of
ciprofloxacin (CPX) on the cell growth, viability,
adherence and morphology of the parasite to evaluate
its potential value in chemotherapy of giardiasis and to
investigate the drug action mechanism(s).
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2. Materials and methods
2.1. Chemicals
Bile bovine, l-cysteine, l-ascorbic acid and ferric
ammonium citrate were obtained from Sigma Chemical
Corp., casitone and yeast extract were obtained from
Difco Laboratories, and bovine serum and antibiotic
solution were obtained from Biochrom K.G. We are
indebted to Bayer for the gift of ciprofloxacin.
2.2. Parasites and cultures
Giardia lamblia [WB strain (ATCC 30957) originally
from a patient with chronic diarrhoea] was obtained
from The American Type Collection, Rockville, MD,
USA. Trophozoites were maintained in axenic culture at
37C in 10 ml Diamond’s TYI-S-33 medium as modified
by Keister (1983), in screw-cap cell culture vials. Peni-
cillin G (250 mg/ml), streptomycin sulfate (250 mg/ml),
gentamicin sulfate (50 mg/ml) and amphotericin B (0.25
mg/ml) were added during routine culture. After 2 days,
the cultures were harvested by cooling the culture vials
at 4C for 15 min and centrifugation at 1200 g for 10
min. Trophozoites were washed three times in Hanks’
balanced salt solution (HBSS; pH 7.1) and cells were
counted in a haemocytometer (Neubaeur cell-counter
chamber). These cells were used as inoculum to study
the effects of CPX on cell growth, viability, morphology
and adherence of G. lamblia trophozoites.
2.3. CPX toxicity studies
An inoculum of 106 trophozoites was exposed to
ciprofloxacin (0.1–2 mg/ml) in HBSS (pH 7.1) for 2 h, at
37C, using 10 ml polystyrene screw-capped vials. Con-
trol experiments were performed under similar experi-
mental conditions without the drug, in the presence of
only the drug solvent (HBSS, pH 7.1). After incubation,
the vials were cooled at 4C and the suspension cen-
trifuged at 1200 g for 10 min. Trophozoites were washed
three times in cold HBSS and the cell pellets were
resuspended in HBSS. Trophozoite viability was
directly determined by phase-contrast microscopy,
counting the live and dead cells in a haemocytometer
(Hill et al., 1986). Parasites were called viable if they
had a characteristic pear-shaped structure, flagellar
motility, normal architecture of ventral disc and refrac-
tory quality. Viability of G. lamblia was also determined
by measure of the oxygen uptake by the trophozoites as
previously described (Sousa and Poiares-da-Silva,
1999a). The effect of CPX was determined by compar-
ing respiratory rates in control cells and in cells pre-
exposed to the drug. To assess cell membrane integrity,
trophozoite suspensions were incubated on ice with an
equal volume of 0.4% trypan blue, and loaded into a
haemocytometer for viable cell counting (Aley et al.,
1994). The experiments were performed three times and
the results were expressed as a percentage of viability.
2.4. Growth inhibition assay
The susceptibility of G. lamblia growth in vitro to
drugs was determined as previously described (Edlind
and Hang, 1990). Cultures of log-phase organisms were
exposed to CPX at various concentrations in fresh
Fig. 1. (A) Killing of Giardia lamblia trophozoites by ciprofloxacin.
Trophozoites were incubated with various concentrations of CPX for
2 h at 37C, and trophozoites viability was determined by trypan blue
exclusion (&), morphology (*) and O2 uptake (*). These dose–
response curves are typical of three independent experiments and error
bars are not indicated since, for most points, they are encompassed by
the size of the symbols. (B) Detachment of trophozoites from the cul-
ture tubes after 2 h at 37C in the presence of ciprofloxacin. Standard
errors of the mean (vertical bars) were calculated from data of three
experiments.
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medium for 48 h. Cell numbers, determined with a hae-
mocytometer, were expressed as a percentage of the cell
number in control cultures.
2.5. Adherence study
The direct effect of CPX on adherence of G. lamblia
trophozoites was evaluated as previously described by
Edlind and Hang (1990). An inoculum of 5105 cells
was distributed into vials (10 ml) and incubated for 2 h
at 37C, in TYI-S-33 medium without antibiotics. Pre-
liminary studies showed that the maximum number of
attached cells was attained at this time. The medium
with unattached cells was discarded and replaced with
prewarmed medium, with and without ciprofloxacin
(0.1–2 mg/ml), and the cultures were incubated for 2 h
at 37C. Adherent cells were dislodged by a 10-min
incubation in ice-cold HBSS, and the number of
attached cells was determined microscopically using a
haemocytometer. The experiments were performed
three times and the results were expressed as number of
attached cells (percentage of control).
2.6. Transmission electron microscopy
Samples were treated as reported previously (Sousa
and Poiares-da-Silva, 1999b). Cell pellets were fixed
with 2.5% glutaraldehyde in 0.1 m sodium cacodylate
buffer (pH 7.0), post fixed in 1% osmium tetroxide and
uranyl acetate, dehydrated in ethanol and in propylene
oxide and embedded in Epon 812 (TAAB 812 resin).
Ultrathin sections were stained with lead citrate and




CPX induces loss of cellular viability. The dose–
response curves obtained for CPX determined by oxy-
gen uptake and those obtained by morphological and
membrane integrity criteria are shown in Fig. 1(A).
These results are expressed as the percentage of inhibi-
tion of the control. The CPX concentration, which
altered the morphology of 19–78% of the cells, inhibited
oxygen uptake by 20–78% of trophozoites and changed
the membrane integrity of 10–79% of cells. The mor-
phological changes in trophozoites, by phase-contrast
microscopy observation, included loss of refractory
quality and the presence of numerous precipitates in the
nucleus, cytoplasm and plasma membrane (not shown).
3.2. Adherence inhibition
G. lamblia trophozoites can attach to in vitro cultured
cells as well as to glass and to a variety of artificial sub-
strates (Kulda and Nohynkova´, 1995). Considering that
inhibition of its attachment may have therapeutic
potential, it was of interest to study the ability of CPX
to promote the G. lamblia detachment. Figure 1(B)
shows that G. lamblia attachment to plastic culture vials
is strongly inhibited by CPX.
3.3. Inhibition of growth in vitro
G. lamblia growth in vitro over 48 h in the presence of
different drug concentrations was measured and expres-
sed as a percentage of the growth in untreated cultures.
Our data showed the inhibition of G. lamblia growth by
ciprofloxacin (Fig. 2).
3.4. Ultrastructural effects of CPX on trophozoites
Transmission electron microscopy of untreated G.
lamblia trophozoites shows that these cells have a typi-
cal cytoskeleton with four pairs of flagella and adhesive
disc, nucleus, and cytoplasm membrane (Plate 1a). CPX
induces morphological changes in cells after exposure for
2 h at 37C. Trophozoites show electron-dense deposits in
the nucleus and cytoplasm, plasma membrane blebbing
and abnormal shape of the nucleus (Plate 1b). Notice the
absence of intact ribosome and cytoplasm precipitation
resulting in the appearance of dense blocks (Plate 1b,c).
The surface vesicles seem to be associated with the dis-
integration of the plasma membrane (Plate 1b,c). The
empty spaces that appear in the cytoplasm indicate that
digestion of intracellular material is occurring in the
presence of CPX. In some cells we see displacement of
cytoskeletal structures, namely the axonemalmicrotubules
that appear dispersed in the cytoplasm (Plate 1c).
Fig. 2. Inhibition of G. lamblia growth in vitro over 48 h by cipro-
floxacin. Standard errors of the mean (vertical bars) were calculated
from data of three experiments.
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4. Discussion
One of the objectives of this work was to evaluate the
potential value of ciprofloxacin in chemotherapy of
giardiasis. Adherence of G. lamblia trophozoites to
enterocytes is essential for colonisation and is con-
sidered to play a crucial role in the pathogenesis of
giardiasis (Farthing, 1997). Therefore, drugs that inhibit
parasite attachment and/or growth have therapeutic
potential. Our experimental data showed in vitro cell
growth inhibition of G. lamblia trophozoites by cipro-
floxacin. CPX caused significant decreases in cell num-
ber at 100 mg/l over 48 h, which is concordant with the
results of a previous study (Ikerd and Koletar, 1993).
When compared to the action of metronidazole which is
considered a ‘‘gold standard’’ antibiotic, the cipro-
floxacin was significantly less active (10-fold) in vitro
against Giardia. However, potential for in vivo activity
may exist, considering that the ciprofloxacin levels
achievable in the gastrointestinal tract inhibit the pro-
liferation of trophozoites (faecal concentrations range
from 185 to 2200 mg/l following a 7-day course of CPX
500 mg by the oral route every 12 h) (Nord, 1988). In
general, the fluoroquinolones have a broader spectrum
of antimicrobial activity, are well tolerated and have an
excellent safety record in long-term therapy (Segev et
al., 1999). Therefore, ciprofloxacin may play an impor-
tant role in the management of drug-resistant giardiasis
or in patients with adverse reactions to other agents.
Another objective of this work was to clarify the drug
action mechanism(s). The present study demonstrates
that CPX inhibits the G. lamblia trophozoite attachment
in vitro, induces morphological alterations and loss of
cell viability. Our data showed a strong correlation
between rupture of the plasma membrane and cell death
induced by CPX. The main ultrastructural alterations
promoted by CPX were ribosome disaggregation, pre-
sence of electron-dense blocks in the cytoplasm and
nucleus, plasma membrane protrusions (blebs), mem-
brane solubilisation and intracellular clearing. The
dense blocks very likely correspond to coagulated pro-
teins and/or products of degradation of ribosomes.
Previous studies with bacteria support the relationship
between membrane damage, ribosome disappearance
and cell death (Silva et al., 1987; Niven et al., 1999). It
has also been demonstrated that Mg2+, acting through
stabilisation of the ribosome, is important for cell via-
bility (Apirakaramwong et al., 1998). Considering these
Plate 1. Transmission electron micrographs of G. lamblia trophozoites (a) Untreated parasites (20,000); (b,c) trophozoites exposed to CPX for 2 h,
at 37C. (b) Note the electron-dense blocks in nucleus and cytoplasm (P), distortion of nucleus morphology and plasma membrane blebs (B)
(15,000). (c) Various dorsal vesicles (V) seem to be associated with plasma membrane rupture (arrowheads), displacement of axonemal micro-
tubules (FA), electron-dense precipitates (P) and empty spaces in cytoplasm (48,000) (N, nucleus; AD, adhesive disc; FA, axonemal microtubules;
VLF, ventrolateral flange; LC, lateral crest).
300 M.C. Sousa, J. Poiares-da-Silva / Toxicology in Vitro 15 (2001) 297–301
findings and that CPX had magnesium-chelating prop-
erties (Stahlmann and Lode, 1999), our results suggest
an interaction of CPX and intracellular Mg2+ that
could be the basis of CPX toxicity.
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